Neuroconcepts, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Neuroconcepts, Inc. makes
Neuroconcepts, Inc. makes EEG analysis software, including principle component EEG analysis software, Uniquant, and quantitative EEG analysis software.
These devices are classified as Class II and are listed in the FDA 510(k) registry; the company is based in the United States.
Catalogue
Principle Component Eeg Analysis Software Ref K951507
Regimes: 510(k) Registry: 510(k)Uniquant Ref K905435
Regimes: 510(k) Registry: 510(k)Quantitative Eeg Analysis Software Ref K951724
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neuroconcepts, Inc. have in the registry?
The registry currently lists 3 devices for Neuroconcepts, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neuroconcepts, Inc.'s devices?
Among its 3 most recently registered devices, Neuroconcepts, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Neuroconcepts, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Neuroconcepts, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neuroconcepts, Inc. in the registry?
The most recently registered devices listed for Neuroconcepts, Inc. include PRINCIPLE COMPONENT EEG ANALYSIS SOFTWARE, UNIQUANT and QUANTITATIVE EEG ANALYSIS SOFTWARE.